-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...
More »SEARCH RESULT
Landmark verdict -V Venkatesan
-Frontline The Supreme Court's ruling against Novartis' patent claim for the cancer drug Glivec paves the way for generic drug companies to keep crucial, life-saving drugs affordable to the common people. By V. VENKATESAN IN their 112-page judgment delivered on April 1, Justice Aftab Alam and Justice Ranjana Prakash Desai of the Supreme Court began with a simple proposition: in order to understand what the law really is, it is essential to...
More »Novartis patent ruling a victory in battle for affordable medicines-Sarah Boseley
-The Guardian Had Novartis won, it would have set a precedent for patenting of other medicines in India, delaying their reaching the poor The battle for affordable, life-saving medicines for poor countries was once waged on first-world city streets with banners and placards. But for some years now it has been a long-hard legal slog in offices and courtrooms. A decade or so ago, it was mostly about access to Aids drugs. Firms...
More »The health of nations
-The Hindu The United Nations has been drawing attention in recent years to the growing burden of non-communicable diseases, which have been adding to morbidity and premature deaths in most countries. In a declaration issued at a high-level meeting in 2011, the U.N. argued that low and middle income countries should actively pursue public health policies that will reduce the incidence of NCDs arising from diabetes, hypertension, high cholesterol, and a...
More »No child left behind -Aarti Dhar
-The Hindu India’s polio triumph is a rare milestone in its uninspiring public health record. The story so far only strengthens the case for a vastly augmented routine immunisation programme to combat disease. India has been celebrating its near-victory over polio for the past two years, but it often hogs the headlines for unacceptably high mortality and morbidity due to other communicable diseases such as malaria, tuberculosis, dengue and filaria. The government now...
More »